Actress and singer Kristin Chenoweth has been named the spokesperson for the campaign “Less Red, More You,” to raise awareness for oxymetazoline hydrochloride (Rhofade; Allergan) cream, 1%. The product is indicated for topical treatment of persistent facial erythema associated with rosacea in adults. It is estimated that 16 million Americans are diagnosed with rosacea.
Ms Chenoweth, who has experienced facial redness from rosacea for years, said after a recommendation from her dermatologist to use oxymetazoline hydrochloride cream, she noticed that the redness on her face has improved.
“I hope that my experience can help make a difference for other sufferers who deal with this challenging condition every day," Ms Chenoweth said.
Two clinical trials for once-daily application of oxymetazoline hydrochloride cream demonstrated a reduction of persistent facial erythema associated with rosacea through 12 hours on day 29. Results were seen in 12%–18% of people using oxymetazoline hydrochloride cream vs 5%–9% of people using vehicle cream. The most common adverse reactions were application site dermatitis, worsening inflammatory lesions of rosacea, application site pruritus, application site erythema, and application site pain.
Actress and singer Kristin Chenoweth has been named the spokesperson for the campaign “Less Red, More You,” to raise awareness for oxymetazoline hydrochloride (Rhofade; Allergan) cream, 1%. The product is indicated for topical treatment of persistent facial erythema associated with rosacea in adults. It is estimated that 16 million Americans are diagnosed with rosacea.
Ms Chenoweth, who has experienced facial redness from rosacea for years, said after a recommendation from her dermatologist to use oxymetazoline hydrochloride cream, she noticed that the redness on her face has improved.
“I hope that my experience can help make a difference for other sufferers who deal with this challenging condition every day," Ms Chenoweth said.
Two clinical trials for once-daily application of oxymetazoline hydrochloride cream demonstrated a reduction of persistent facial erythema associated with rosacea through 12 hours on day 29. Results were seen in 12%–18% of people using oxymetazoline hydrochloride cream vs 5%–9% of people using vehicle cream. The most common adverse reactions were application site dermatitis, worsening inflammatory lesions of rosacea, application site pruritus, application site erythema, and application site pain.
Actress and singer Kristin Chenoweth has been named the spokesperson for the campaign “Less Red, More You,” to raise awareness for oxymetazoline hydrochloride (Rhofade; Allergan) cream, 1%. The product is indicated for topical treatment of persistent facial erythema associated with rosacea in adults. It is estimated that 16 million Americans are diagnosed with rosacea.
Ms Chenoweth, who has experienced facial redness from rosacea for years, said after a recommendation from her dermatologist to use oxymetazoline hydrochloride cream, she noticed that the redness on her face has improved.
“I hope that my experience can help make a difference for other sufferers who deal with this challenging condition every day," Ms Chenoweth said.
Two clinical trials for once-daily application of oxymetazoline hydrochloride cream demonstrated a reduction of persistent facial erythema associated with rosacea through 12 hours on day 29. Results were seen in 12%–18% of people using oxymetazoline hydrochloride cream vs 5%–9% of people using vehicle cream. The most common adverse reactions were application site dermatitis, worsening inflammatory lesions of rosacea, application site pruritus, application site erythema, and application site pain.
